Flu vaccines that take a page from the COVID-19 vaccine platform are making progress in clinical trials.
In a phase 3 trial, Pfizer’s mRNA flu vaccine outperformed a traditional vaccine, researchers report in the Nov. 20 New…
mRNA flu vaccines are making their way through clinical trials
